John Schmid Insider Profile
312 Followers
John Schmid, CFO at Auspex Pharma, holds 31.62K shares in AnaptysBio (Ticker: ANAB), holds 30.00K shares in BridgeBio Oncology Therapeutics (Ticker: BBOT), holds 0.00 shares in Poseida Therapeutics (Ticker: PSTX). Most recently, John Schmid Sold ― shares of AnaptysBio on Apr 01, 2026 for an estimated value of $1.16M.
Profitable Transactions
6 out of 7 Profitable Transactions
Average Return
+107.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Schmid holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 12, 2024 - Aug 12, 2025
Return:+224.40%
The most profitable trade made by John Schmid
John Schmid's Trading History
Auspex Pharma
May 05, 2015
―
Uninformative Sell
―
―
Neos Therapeutics
Mar 19, 2021
―
Uninformative Sell
―
$0.00
AnaptysBio
Apr 01, 2026
Director
Informative Sell
1.16M
$2.11M
Xeris Pharmaceuticals
Aug 13, 2024
Director
Informative Buy
10.11K
$868.89K
Poseida Therapeutics
Jan 08, 2025
―
Uninformative Sell
―
$0.00
Design Therapeutics
Mar 25, 2024
Director
Informative Buy
99.66K
$766.60K
BridgeBio Oncology Therapeutics
Aug 11, 2025
Former Director
Uninformative Buy
301.80K
$251.70K
Trius Therap
Aug 02, 2010
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see John Schmid's performance on stock
You May Also Like
John Schmid insider profile FAQ
What is the percentage of profitable transactions made by John Schmid?
The percentage of profitable transactions made by John Schmid is 86%.
What is the average return per transaction made by John Schmid?
The average return per transaction made by John Schmid is 107.60%.
What stocks does John Schmid hold?
John Schmid holds: ASPX, NEOS, ANAB, XERS, PSTX, DSGN, BBOT, TSRX stocks.
What was John Schmid’s latest transaction?
John Schmid latest transaction was an Informative Sell of $1.16M.
What was John Schmid's most profitable transaction?
John Schmid’s most profitable transaction was an Informative Buy of XERS stock on August 12, 2024. The return on the trade was 224.40%.
What is John Schmid's role in Auspex Pharma?
John Schmid's role in Auspex Pharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.